RPL12P13

Across TCGA pan-cancer cohorts, RPL12P13 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RPL12P13’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL12P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL12P13 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD, KIRC, and LUSC are the cancer types where RPL12P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL12P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.397	<.001	8	view →
KIRC	All	All	+0.135	<.001	8	view →
LUSC	All	All	+0.198	<.001	6	view →
LUAD	Male	All	+0.447	<.001	5	view →
KIRP	All	III,IV	+0.170	.015	4	view →
READ	All	All	+0.421	.005	2	view →
CHOL	All	All	+0.388	.008	2	view →
KICH	Female	All	−0.202	.017	2	view →
PRAD	All	All	+0.161	.017	2	view →
LIHC	All	II,III,IV	+0.092	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

RPL12P13–COAD

Open the COAD breakdown →